NYSCF and CMTA Collaborate to Advance Research for Neuropathies
Press Release
NYSCF and the Charcot-Marie-Tooth Association (CMTA), a patient-led disease foundation with a mission to advance research on genetic neuropathies leading to the development of new therapies, partnered to research and, ultimately, find cures for Charcot-Marie-Tooth disease and other genetic neuropathies.
The immediate aim of the collaboration is to develop a bank of induced pluripotent stem cell lines for a variety of neuropathy disorders of known genetic causation, with a goal of eventually developing personalized drug therapies.